Hello Again!

Executive Director Clinical Pharmacology / Pharmacometrics Needed! This role 
will require you to be on site 3-4 days a week and you'll most likely need to 
relocate for the role. East Coast! Report directly to the VP of the group of 12 
or so CP and Pmx scientists. Please contact me to learn more.

This company has 30-40 assets in or approaching the clinic and is growing their 
team with new roles this year.

Lead the pharmacometrics function within oncology and other therapeutic areas, 
providing scientific, technical, and strategic direction.
Oversee the development and implementation of Model Informed Drug Development 
(MIDD) plans, including the planning and execution of quantitative analyses 
such as population pharmacokinetics, PK/PD, exposure-response, disease 
progression modeling, model-based meta-analysis, and decision analysis. Develop 
and conduct individual MIDD plans and analyses as needed.
Work with / Manage a large team of pharmacometricians and/or other 
computational scientists.
Train, develop, and mentor pharmacometricians and other MIDD colleagues.
Forecast pharmacometrics resourcing needs within the oncology therapeutic area.
Provide guidance on regulatory MIDD strategy.
Contribute to the enhancement of tools, processes, and methodologies, 
participating in internal cross-functional workgroups, external alliances, 
committees, consortia, and academic collaborations.
Influence and lead the external environment through participation in scientific 
societies, publications, presentations, and collaborations.

Please message me to learn more.

Thank you as always!
TJ


TJ Elder
President
Pre-Clinical Development
O: 413.458.6124
C: 413.207.7676
https://www.linkedin.com/in/tjelder/
tel...@stem-sourcing.com<mailto:tel...@stem-sourcing.com>


[cid:image001.png@01DAAC24.7D1CF1E0]<http://www.stem-sourcing.com/>

Please Note:
The information in this e-mail message is legally privileged and confidential 
information intended only for the use of the addressee(s) named above.  If you, 
the reader of this message, are not the intended recipient, you are hereby 
notified that you should not further disseminate, distribute, or forward this 
e-mail message.  If you have received this e-mail in error, please notify the 
sender as soon as possible.  In addition, please delete the erroneously 
received message from any device/media where the message is stored.

Reply via email to